Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The UGT2B17 gene deletion is not associated with prostate cancer risk.

The Prostate - 1 Apr 2008

Olsson Mats, Lindström Sara, Häggkvist Benjamin, Adami Hans-Olov, Bälter Katarina, Stattin Pär, Ask Birgitta, Rane Anders, Ekström Lena, Grönberg Henrik

Abstract excerpt

BACKGROUND: Deletion polymorphism of the UDP-glucuronosyltransferase 2B17 (UGT2B17) gene has been associated with an increased prostate cancer risk in two previous independent studies. Here we determine the risk in a large-scale population-based case-control study. METHODS: Genotyping was conduct...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Gene Deletion
Share to Glucuronosyltransferase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Minor Histocompatibility Antigens

Share to Prostatic Neoplasms

Share to Risk Factors

Share to Sweden

Source

Identifiers

PMID: 18247404
DOI: 10.1002/pros.20700

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18247404-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

The UGT2B17 gene deletion is not associated with prostate cancer risk.PMID 18247404Read ↗

Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate.Semantic proximity Read ↗

Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.Semantic proximity Read ↗

Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.Semantic proximity Read ↗

Meta-analysis reveals a lack of association between UGT2B17 deletion polymorphism and tumor susceptibility.Semantic proximity Read ↗

Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.Semantic proximity Read ↗

Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism.Semantic proximity Read ↗

UGT2B17 gene deletion associated with an increase in bone mineral density similar to the effect of hormone replacement in postmenopausal women.Semantic proximity Read ↗

No association of the 5' promoter region polymorphism of CYP17 gene with prostate cancer risk.Semantic proximity Read ↗

The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.Semantic proximity Read ↗

A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk.Semantic proximity Read ↗

The MTHFR 677C --> T polymorphism and risk of prostate cancer: results from the CAPS study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.